Journal of Ophthalmic Inflammation and Infection · 2015 · 19 citations · 9 references
MedicineOncologyOphthalmologyChemotherapyMetastasisOcular OncologyIntraocular LymphomaOcular Tumor ImagingOcular Tumor PathologyOcular TumorsSystemic Therapy For Ocular MalignanciesAnterior Segment Ultrasound BiomicroscopyCombination Chemotherapy ResistanceIntraocular MetastasisIntravitreal ChemotherapyIris MetastasesNon-hodgkin Lymphoma TherapyOcular LymphomaOcular Metastasis
BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin's lymphoma that rarely metastasizes to the iris and the anterior segment. Blastic/pleomorphic morphology is thought to have an adverse effect on prognosis in MCL. MCL is resistant to conventional chemotherapeutic regimens with a tendency for multiple relapses. Management of anterior segment metastasis of systemic MCL has not been described in literature. FINDINGS: A 58-year-old male presented with an aggressive, relapsing, metastatic, systemic blastic variant of MCL with ocular involvement. At the time of initial presentation, large tumor cells were visible in the anterior chamber (AC) along with hypopyon and fibrin. The AC cells stained positively for CD20. The iris was thickened and coated with lymphoma cells. Iris neovascularization was present. Given extensive systemic and ocular involvement, the patient was given combination chemotherapy with systemic ibrutinib and intravitreal injections of methotrexate and rituximab. The disease response was monitored using multimodal imaging, including anterior segment optical coherence tomography and ultrasound biomicroscopy. Following combination of systemic and intraocular chemotherapy, there was a marked decrease in the ocular tumor load and the systemic disease. CONCLUSIONS: Combination therapy with intravitreal injections of chemotherapeutic agents targeting monoclonal B-cell population and novel systemic agents may help to achieve remission in anterior segment metastasis of aggressive subtypes of NHL such as blastic variant of MCL. Multimodal imaging may assist in the management of these cases.
9
Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet · 2013 · 1.5K citations
Medicine, Oncology, Pharmacology +6
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
Kelly Larkin, Ujwala S. Saboo, Grant M. Comer et al. · British Journal of Ophthalmology · 2013 · 106 citations
David Ritchie, John F. Seymour, Andrew Grigg et al. · Annals of Hematology · 2006 · 72 citations
Medicine, Hematology, Oncology +15
Mantle cell lymphoma in the orbital and adnexal region
P Rasmussen, L D Sjo, Jan Ulrik Prause et al. · British Journal of Ophthalmology · 2009 · 69 citations · Full text